CS203587A2 - Method of 5-chloro-7-iodo-8-hydroxyquinoline's pharmaceutically pure zinc complex preparation - Google Patents

Method of 5-chloro-7-iodo-8-hydroxyquinoline's pharmaceutically pure zinc complex preparation

Info

Publication number
CS203587A2
CS203587A2 CS872035A CS203587A CS203587A2 CS 203587 A2 CS203587 A2 CS 203587A2 CS 872035 A CS872035 A CS 872035A CS 203587 A CS203587 A CS 203587A CS 203587 A2 CS203587 A2 CS 203587A2
Authority
CS
Czechoslovakia
Prior art keywords
hydroxyquinoline
iodo
chloro
zinc complex
pure zinc
Prior art date
Application number
CS872035A
Other languages
English (en)
Other versions
CS269993B2 (en
Inventor
Gyula Dr Sebestyen
Istvan Dr Simonyi
Gizella Dr Miholics
Marta Dr Kovacs
Frigyes Dr Gorgenyi
Marton Dr Fekete
Pal Dr Vago
Istvan Seres
Janos Egri
Maria Szeli
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of CS203587A2 publication Critical patent/CS203587A2/cs
Publication of CS269993B2 publication Critical patent/CS269993B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C07D215/30—Metal salts; Chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CS872035A 1986-04-18 1987-03-25 Method of 5-chloro-7-iodo-8-hydroxyquinoline's pharmaceutically pure zinc complex preparation CS269993B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU861623A HU196554B (en) 1986-04-18 1986-04-18 Process for production of medical compounds with fungicidal effect

Publications (2)

Publication Number Publication Date
CS203587A2 true CS203587A2 (en) 1989-04-14
CS269993B2 CS269993B2 (en) 1990-05-14

Family

ID=10955373

Family Applications (1)

Application Number Title Priority Date Filing Date
CS872035A CS269993B2 (en) 1986-04-18 1987-03-25 Method of 5-chloro-7-iodo-8-hydroxyquinoline's pharmaceutically pure zinc complex preparation

Country Status (24)

Country Link
US (2) US4868172A (cs)
JP (1) JPS62294616A (cs)
KR (1) KR870010036A (cs)
CN (1) CN1021632C (cs)
AU (1) AU601725B2 (cs)
BE (1) BE1001251A4 (cs)
BG (1) BG47945A3 (cs)
CA (1) CA1306685C (cs)
CH (1) CH671880A5 (cs)
CS (1) CS269993B2 (cs)
DE (1) DE3713372A1 (cs)
DK (1) DK200087A (cs)
ES (1) ES2005165A6 (cs)
FI (1) FI871703A7 (cs)
FR (1) FR2597343B1 (cs)
GB (1) GB2189144B (cs)
GR (1) GR870617B (cs)
HU (1) HU196554B (cs)
IL (1) IL82238A0 (cs)
IT (1) IT1207583B (cs)
NL (1) NL8700906A (cs)
PL (1) PL265249A1 (cs)
SE (1) SE8701592L (cs)
YU (1) YU46313B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0355383A1 (de) * 1988-07-28 1990-02-28 Ciba-Geigy Ag Solubilisierungsverfahren
DE69013477T2 (de) * 1989-06-12 1995-02-23 Shiseido Co Ltd Mittel gegen juckreiz.
US5219847A (en) * 1989-06-12 1993-06-15 Shiseido Company, Ltd. Antipruritic composition
US7846919B2 (en) * 1998-02-10 2010-12-07 Dermex Pharmaceuticals, Llc Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
US9089730B2 (en) * 2010-11-25 2015-07-28 Zzakey Technologies Ltd Biodegradable fire-fighting formulation
CN111937886A (zh) * 2019-05-16 2020-11-17 兰州大学 一种8-羟基喹啉配合物的制备及其在防治植物病害中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH494760A (de) * 1962-11-30 1970-08-15 Metalsalts Corp Verfahren zur Herstellung von Metall-8-chinolinolaten mit Ausnahme der Alkalimetallderivate
US3886277A (en) * 1967-02-14 1975-05-27 Schwarzkopf Gmbh Hans Methods of controlling dandruff using 5,7-dichloro-8-hydroxy quinoline
BE755584A (fr) * 1969-09-19 1971-03-01 Ugine Kuhlmann Nouveaux medicaments a activite amoebicide
DE2154020A1 (de) * 1971-10-29 1973-05-03 Hoechst Ag Metallkomplexe von substituierten benzimidazolen
NO156672C (no) * 1975-10-24 1987-11-04 Chapman Chem Co Preparat med antimikrobiell og eventuelt insekticid virkning og anvendelse av et slikt preparat som tre- og vekstbeskyttelsesmiddel.
ZA786259B (en) * 1977-11-09 1979-10-31 Procter & Gamble Therapeutic composition
DE3129685C2 (de) * 1981-07-28 1986-11-06 geb. Stoffel Annemarie Dr. 7802 Merzhausen Buck Antiseptische Lösung

Also Published As

Publication number Publication date
FR2597343B1 (fr) 1991-11-29
SE8701592D0 (sv) 1987-04-16
GB2189144A (en) 1987-10-21
CN87102747A (zh) 1987-12-09
PL265249A1 (en) 1988-07-21
DK200087A (da) 1987-10-19
CS269993B2 (en) 1990-05-14
US4868172A (en) 1989-09-19
GR870617B (en) 1987-08-18
JPH0525858B2 (cs) 1993-04-14
IL82238A0 (en) 1987-10-30
AU7175887A (en) 1987-10-22
JPS62294616A (ja) 1987-12-22
CN1021632C (zh) 1993-07-21
SE8701592L (sv) 1987-10-19
CA1306685C (en) 1992-08-25
BG47945A3 (bg) 1990-10-15
FI871703A7 (fi) 1987-10-19
YU46313B (sh) 1993-05-28
HUT43781A (en) 1987-12-28
GB2189144B (en) 1990-04-25
BE1001251A4 (fr) 1989-09-05
IT1207583B (it) 1989-05-25
KR870010036A (ko) 1987-11-30
FR2597343A1 (fr) 1987-10-23
CH671880A5 (cs) 1989-10-13
US4871728A (en) 1989-10-03
DK200087D0 (da) 1987-04-15
DE3713372A1 (de) 1987-10-22
HU196554B (en) 1988-12-28
ES2005165A6 (es) 1989-03-01
YU69387A (en) 1988-12-31
IT8720168A0 (it) 1987-04-17
AU601725B2 (en) 1990-09-20
DE3713372C2 (cs) 1991-12-19
FI871703A0 (fi) 1987-04-16
GB8709166D0 (en) 1987-05-20
NL8700906A (nl) 1987-11-16

Similar Documents

Publication Publication Date Title
PL264982A1 (en) Method of obtaining pharmaceutically acceptable amidipine salt
AU7315587A (en) Sportman's article of equipment
CS579987A2 (en) Method of a and b phamotidine's pure forms winning
CS9787A2 (en) Method of hyaluronic acid's insulation
CS392785A2 (en) Method of 1,3-oxazolidine-2-onane's derivatives preparation
AU7390787A (en) Open `d' ring hormone analogs
CS203587A2 (en) Method of 5-chloro-7-iodo-8-hydroxyquinoline's pharmaceutically pure zinc complex preparation
EP0267761A3 (en) Preparation process of 4,4'-dihydroxybiphenyl
CS186887A2 (en) Method of alkylsuphonyl-alkylchlorobenzenes preparation
GB8727401D0 (en) Preparation of trifluoromethylbenzonitrile
CS8703287A1 (en) Method of 2-benzothiazolsulphenic acid's sulphenamides preparation
EP0240362A3 (en) Process for the preparation of 4'-hydroxybiphenyl-4-carboxylic acid
GB2196961B (en) Preparation of polyfluoroenolates
IL83539A (en) Method of preparation of anilinofumarate
GB2187737B (en) Preparation of 2,6-dihalo-4-cyanophenol esters
CS810187A2 (en) Method of 2-guanidinothiazole's derivative production
GB8703882D0 (en) Preparation of encainide
CS846387A1 (en) Method of naphthoylenbenzimidazole's transisomer's pure koh addition compound preparation
CS275186B2 (en) Method of 7-aminocephalosporaneic acid's preparation
CS536288A1 (en) Method of oxyhaemoglobin's purified solution preparation
CS501588A1 (en) Method of copper-magnesium double cyclo-tetraphosphates' high-temperature preparation
GB2188627B (en) Preparation of 3-dimethylamino-7-methyl-1 2 4-benzotriazine-1-oxide
MN333A8 (en) Preparation method of the "chigatussin" medicine
EP0373919A3 (en) Process for the preparation of 2'-deoxy-beta-adenosine
CS542187A1 (en) Method of 4-oxopentylaikanoates' synthesis